Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Titan Pharma (TTNP)

3.45   -0.06 (-1.71%) 02-25 12:07
Open: 3.48 Pre. Close: 3.51
High: 3.77 Low: 3.41
Volume: 950,087 Market Cap: 34M
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform that focuses primarily on the treatment for chronic diseases. The company also develops ProNeura-Ropinirole, an implant to provide delivery of ropinirole, a dopamine agonist for the treatment of Parkinson's disease; and triiodothyronine, an implant for the treatment of hypothyroidism. Titan Pharmaceuticals, Inc. was incorporated in 1992 and is based in South San Francisco, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.582 - 3.603 3.603 - 3.624
Low: 3.311 - 3.335 3.335 - 3.359
Close: 3.471 - 3.508 3.508 - 3.544

Technical analysis

as of: 2021-02-25 11:51:56 AM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 4.71     One year: 5.38
Support: Support1: 3.10    Support2: 2.58
Resistance: Resistance1: 4.03    Resistance2: 4.61
Pivot: 3.77
Moving Average: MA(5): 3.61     MA(20): 3.65
MA(100): 3.78     MA(250): 6.36
MACD: MACD(12,26): 0.05     Signal(9): 0.09
Stochastic oscillator: %K(14,3): 21.00     %D(3): 27.72
RSI: RSI(14): 48.00
52-week: High: 16.50  Low: 2.70  Change(%): -55.0
Average Vol(K): 3-Month: 455971  10-Days: 255332

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
TTNP has closed above bottom band by 23.1%. Bollinger Bands are 41% narrower than normal. The narrow width of the bands suggests low volatility as compared to TTNP's normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Wed, 24 Feb 2021
Titan Pharmaceuticals Inc. (TTNP) Soars 4.78% on February 24 -

Thu, 18 Feb 2021
Titan Pharmaceuticals Inc. (TTNP) Soars 14.37% on February 18 -

Fri, 12 Feb 2021
Titan Pharmaceuticals Inc. (TTNP) Soars 3.39% on February 12 -

Wed, 10 Feb 2021
Should You Buy Titan Pharmaceuticals, Inc. common stock (TTNP) Stock on Wednesday? - InvestorsObserver

Tue, 09 Feb 2021
Titan Pharmaceuticals Inc. (TTNP) Soars 8.74% on February 09 -

Mon, 08 Feb 2021
Titan Pharmaceuticals Inc. (TTNP) Soars 6.58% on February 08 -

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Underperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Outperform Debt to Equity: Underperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 10
Shares Float (M) 5
% Held by Insiders 5.08
% Held by Institutions 3.53
Shares Short (K) 510
Shares Short P. Month (K) 835

Stock Financials

EPS -7.077
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) -0.230
Profit Margin
Operating Margin -341.68
Return on Assets (ttm) -160.2
Return on Equity (ttm)
Qtrly Rev. Growth 18.3
Gross Profit (p.s.) -0.499
Sales Per Share 0.507
EBITDA (p.s.) -1.703
Qtrly Earnings Growth
Operating Cash Flow (M) -16
Levered Free Cash Flow (M) -11

Stock Valuations

PE Ratio -0.50
PEG Ratio
Price to Book value -15.26
Price to Sales 6.92
Price to Cash Flow -2.12

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.